Search results
Results from the WOW.Com Content Network
Launch of the Coalition for Epidemic Preparedness Innovations, CEPI in 2017 at the World Economic Forum in Davos, Switzerland. The Coalition for Epidemic Preparedness Innovations (CEPI) is a foundation that takes donations from public, private, philanthropic, and civil society organisations, to finance independent research projects to develop vaccines against emerging infectious diseases (EID).
The Confederation of European Paper Industries (CEPI) is the pan-European association representing the forest fibre and paper industry. Through its 18 national associations, CEPI gathers 495 companies operating more than 900 pulp and paper mills across Europe producing paper, cardboard, pulp and other bio-based products. CEPI represents 22% of ...
Richard Hatchett is an American oncologist [1] and epidemiologist who has been serving as chief executive officer of the Coalition for Epidemic Preparedness Innovations (CEPI) in Oslo and London since 2017. [2] [3] He was awarded the Secretary of Health and Human Services's Award for Distinguished Service. [4]
Cepi may refer to: Čepí, a village in the Pardubice Region of the Czech Republic. Coalition for Epidemic Preparedness Innovations, a Norway-based foundation that finances vaccine development; Confederation of European Paper Industries, a pan-European association representing the forest fibre and paper industry; Frank Cepollina, American engineer
In 2017, Robinson began serving on CEPI's scientific advisory board. He was made vice-chair in 2019. [3] On February 16, 2022, Robinson was awarded a two-year, $340,000 grant by the Arnold Ventures Foundation to study biosimilars to determine potential cost savings from wider use of them. [4]
Website: www.cepi.cz: Čep ... Official website This page was last edited on 13 September 2024, at 07:22 (UTC). Text is available ...
The Centre for International Intellectual Property Studies, or Centre d'Études Internationales de la Propriété Intellectuelle (CEIPI) in French (formerly the "Centre for International Industrial Property Studies", or "Centre d'Études Internationales de la Propriété Industrielle" in French), is a Strasbourg, France-based training centre for specialists in intellectual property law.
CEPI granted Novavax up to $399 million to support the development of the candidate vaccine. [34] On 6 September 2021, Novavax and Takeda Pharmaceutical Company announced that the Government of Japan's Ministry of Health, Labour and Welfare will purchase 150 million doses of Novavax's vaccine candidate TAK-019 pending regulatory approval. [35]